SUMAR Biotech LLP, registered in January 2018, is a startup approved by Gujarat State Biotechnology Mission. SUMAR Biotech LLP was started by emerging entrepreneurs and a team of young but experienced research scientists and manufacturing professionals. We work together to innovate and manufacture Semi-synthetic, synthetic and Fermentation API. Our R&D set up is equipped with state-of-the-art facility for synthesis, extraction, isolation and purification of products from upstream (fermentation) process.

Sidmak Laboratories (India) Pvt.Ltd With an asset of more than 500 qualified employees and World Standard Development And Manufacturing Facilities in Dehradun, Valsad with an expertise For a range of formulations from tablets,capsules , Trans-dermal drug delivery dosage form, Sidmak India is poised for being among the fast growing pharmaceutical companies.  Pioneering efforts of Sidmak India in providing Quality Healthcare Products Developed And Manufactured from world- class state-of-the-art facilities.

Preeclampsia is a condition that affects the placenta during pregnancy and is dangerous for both the fetus and the mother. Scientists from the Institut Pasteur, Inserm and the CNRS have proposed a new therapy, tested in two rodent models, that corrects the defects identified in placental cells, and restores placental and fetal weight. The treatment successfully lowers blood pressure in the mother and resolves the characteristic preeclampsia symptoms of excess protein in urine and cardiovascular abnormalities.

Are would-be parents carrying a genetic risk of serious illnesses that they could potentially pass on to their children? In the USA, doctors recommend that couples have genetic screening before trying to conceive. Researchers at the University of Zurich have now shown that a maximal variant of this test detects the risk in 44 percent of couples who are related by blood, and in just 5 percent of other couples. Non-hereditary newly acquired mutations are a major reason for the reduced detection rate in the latter.

Young people living with a genetic alteration that increases the risk of psychiatric disorders have markedly different brain activity during sleep, a study led by researchers from the Universities of Bristol and Cardiff published today in eLife shows.

The brain activity patterns during sleep shed light on the neurobiology behind a genetic condition called 22q11.2 Deletion Syndrome (22q11.2DS) and could be used as a biomarker to detect the onset of neuropsychiatric disorders in people with 22q11.2DS.

Soon India will get its first made in India vaccine against cervical cancer which is developed by Serum Institute of India (SII) and the Department of Biotechnology (DBT). The daid vaccine is Quadrivalent Human Papillomavirus vaccine (qHPV).

The Laboratory was established in 1941 as a research and production centre, known as Drug Research Laboratory of J&K State and was later taken over by Council of Scientific & Industrial Research (CSIR) of Govt. of India in December 1957 as Regional Research Laboratory, Jammu. In view of  its core strength in natural products based drug discovery, the mandate of  Institute was redefined in 2005 and its name changed to Indian Institute of Integrative Medicine.

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Zydus Lifesciences initiates Phase IV clinical trial for Desidustat in patients with Chronic Kidney Disease (CKD) induced anemia.

Desidustat sold under a brand name Oxemia which is a prescription drug approved in India for patients with Chronic Kidney Disease (CKD) induced anemia, and can be taken only under the advice and guidance of a Nephrologist or an internal medicine specialist.

Hikma Pharmaceuticals and Glenmark Specialty S.A., a subsidiary of Glenmark Pharma launches Ryaltris in the US. It is a combination of olopatadine hydrochloride and mometasone furoate and formulated as a nasal spray. Ryaltris is approved by the US Food and Drug Administration (FDA) for the treatment of symptoms of seasonal allergic rhinitis (SAR) in adult and pediatric patients 12 years of age and older.

Anna University was established on 4th September, 1978 as a unitary type of University. This University was named after Late Dr.C.N.Annadurai, former Chief Minister of Tamil Nadu. It offers higher education in Engineering, Technology, Architecture and Applied Sciences relevant to the current and projected needs of the society. Besides promoting research and disseminating knowledge gained therefrom, it fosters cooperation between the academic and industrial communities.

Pinnacle Life Science is a 100% subsidiary of India’s most trusted pharmaceutical company Aarti Drugs Ltd (ADL) and forms part of $ 1.5 billion conglomerate of the esteemed Aarti Group of Industries.  With 35 years of healthcare commitment through Aarti Drugs, Pinnacle has made its presence in nearly 90+ countries. Treading carefully on the path of efficient healthcare, the state-of-the-art manufacturing facility is designed to produce formulations that meet international quality standards and stringent regulatory compliances to trade beyond borders.

Delhi Pharmaceutical Sciences and Research University (DPSRU) is the first Pharmacy University in India and third in the world, established by Act 07 of 2008 State legislature of Delhi and functional from 2015. It is 100% grant-in-aid State Government University recognized under 2f and Section 22 of the UGC. The University has the legacy of 57 years starting with the D. Pharm.

Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized skills across more than 40 industries, we offer Strategy and Consulting, Technology and Operations services, and Accenture Song all powered by the world’s largest network of Advanced Technology and Intelligent Operations centers.

Post : Drug Safety Associate

Union Minister of Chemical and Fertilizers, Dr. Mansukh Mandaviya urges pharma industries to produce medicines and bring innovative research with the goal of ensuring good health and well-being of the people, not only for commercial purpose.

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

Heart attacks in women are more likely to be fatal than in men. The reasons are differences in age and in comorbidity burden which makes risk assessment in women a challenge. Researchers at the University of Zurich have now developed a novel artificial-intelligence-based risk score that improves personalized care for female patients with heart attacks.

A study of mice found that dietary sugar alters the gut microbiome, setting off a chain of events that leads to metabolic disease, pre-diabetes, and weight gain.

The findings, published today in Cell(link is external and opens in a new window), suggest that diet matters, but an optimal microbiome is equally important for the prevention of metabolic syndrome, diabetes, and obesity.
Diet alters microbiome.

Malabar Cancer Centre, Thalassery (MCC) is an autonomous institution under Health and Family Welfare Department, Government of Kerala, established under Societies Registration Act XXI of 1860. The institution is located at Kodiyeri, Thalassery of Kannur District and was established in 2001 and the clinical services were started in the same year.